About

Niraparib is used as first-line maintenance treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients with a certain type of inherited (germline) abnormal BRCA gene or a positive tumor test for genomic instability called homologous recombination deficiency (HRD). It is also used as maintenance treatment of recurrent (cancer that comes back) ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients with a certain type of inherited (germline) abnormal BRCA gene. Your doctor will test for the presence of this gene (deleterious or suspected deleterious germline BRCA gene) and genomic instability. This medicine is used in patients who have had received platinum-based cancer medicines.

This medicine is available only with your doctor's prescription.

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.